Sukhwinder Singh Rai - Nov 10, 2022 Form 3 Insider Report for Skye Bioscience, Inc. (SKYE)

Role
Director
Signature
/s/ Kaitlyn Arsenault, as Attorney-in-Fact
Stock symbol
SKYE
Transactions as of
Nov 10, 2022
Transactions value $
$0
Form type
3
Date filed
11/15/2022, 11:16 AM
Next filing
Nov 15, 2022

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney